Tulsi Naidu - Zurich Insurance CEO Committee
| ZURN Stock | CHF 558.60 2.60 0.47% |
Insider
Tulsi Naidu is CEO Committee of Zurich Insurance Group
| Age | 50 |
| Phone | 41 44 625 25 25 |
| Web | https://www.zurich.com |
Zurich Insurance Management Efficiency
The company has return on total asset (ROA) of 0.0114 % which means that it generated a profit of $0.0114 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1633 %, meaning that it generated $0.1633 on every $100 dollars invested by stockholders. Zurich Insurance's management efficiency ratios could be used to measure how well Zurich Insurance manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Heidi Hinterhuber | Swiss Life Holding | N/A | |
| Robert Karofsky | UBS Group AG | 56 | |
| Barbara Schadler | Roche Holding AG | 61 | |
| Kian Koh | UBS Group AG | 63 | |
| Samir MD | Novartis AG | N/A | |
| Stefan Machler | Swiss Life Holding | 63 | |
| Klaus Moosmayer | Novartis AG | 55 | |
| Guido Furer | Swiss Re AG | 60 | |
| Sarah Youngwood | UBS Group AG | 49 | |
| Hermann Geiger | Swiss Re AG | 60 | |
| Tanguy Polet | Swiss Life Holding | 53 | |
| BA MPP | Swiss Re AG | 62 | |
| Markus Leibundgut | Swiss Life Holding | 54 | |
| Vasant Narasimhan | Novartis AG | 47 | |
| Christian Mumenthaler | Swiss Re AG | 54 | |
| Elena Logutenkova | Swiss Re AG | N/A | |
| Youngran Kim | Swiss Re AG | N/A | |
| Christian Bluhm | UBS Group AG | 54 | |
| Pascale Schmidt | Roche Holding AG | 50 | |
| Michael Dargan | UBS Group AG | 46 | |
| Jorg Arnold | Swiss Life Holding | 59 | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0114 |
Zurich Insurance Leadership Team
Elected by the shareholders, the Zurich Insurance's board of directors comprises two types of representatives: Zurich Insurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zurich. The board's role is to monitor Zurich Insurance's management team and ensure that shareholders' interests are well served. Zurich Insurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zurich Insurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Committee | ||
| Sierra Signorelli, CEO Committee | ||
| George Quinn, Group Committee | ||
| Mario Greco, Group Committee | ||
| Ericson Chan, Group Committee | ||
| Kristof Terryn, CEO Committee | ||
| Jeffrey Dailey, Inc Group | ||
| Tulsi Naidu, CEO Committee | ||
| Peter Giger, Group Committee | ||
| Alison Martin, CEO Committee |
Zurich Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zurich Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0114 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 73.84 B | |||
| Shares Outstanding | 147.53 M | |||
| Shares Owned By Insiders | 0.18 % | |||
| Shares Owned By Institutions | 40.57 % | |||
| Price To Earning | 18.18 X | |||
| Price To Book | 2.55 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Zurich Stock Analysis
When running Zurich Insurance's price analysis, check to measure Zurich Insurance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zurich Insurance is operating at the current time. Most of Zurich Insurance's value examination focuses on studying past and present price action to predict the probability of Zurich Insurance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zurich Insurance's price. Additionally, you may evaluate how the addition of Zurich Insurance to your portfolios can decrease your overall portfolio volatility.